Robert L. King is a notable inventor based in Eagle Pass, TX (US). He has made significant contributions to the field of cancer research through his innovative work. With a total of 3 patents, his inventions focus on the genetic aspects of cancer susceptibility.

Latest Patents

One of his latest patents involves the 3' untranslated region of the human prohibitin gene. This region has been isolated for use in a cancer susceptibility screen and as a therapeutic agent for the treatment of cancer. His work in this area has the potential to advance cancer treatment and improve patient outcomes.

Career Highlights

Robert L. King is affiliated with the Oklahoma Medical Research Foundation, where he conducts his research. His work is pivotal in understanding the genetic factors that contribute to cancer susceptibility.

Collaborations

He has collaborated with esteemed colleagues such as Eldon R. Jupe and Xiao-Tie Liu, further enhancing the impact of his research.

Conclusion

Robert L. King's contributions to cancer research through his patents and collaborations highlight his dedication to innovation in the medical field. His work continues to pave the way for advancements in cancer treatment.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]